Who is sponsoring NCT05206968?

NCT05206968 is sponsored by University Tunis El Manar.

What drugs are being tested in NCT05206968?

Interventions in NCT05206968: pelvic radiograph.

What condition does NCT05206968 study?

NCT05206968 studies Juvenile Idiopathic Arthritis Hip.

Is NCT05206968 still recruiting?

NCT05206968 is currently status unknown. Last updated 25 January 2022.

Last reviewed 2022-01-25 · How we verify

NCT05206968: hip index

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Scoring System of Structural Damage for the Hip in Juvenile Idiopathic Arthritis

Status unknown Last updated 25 January 2022

What this trial tests

trial testing pelvic radiograph in Juvenile Idiopathic Arthritis Hip in 45 participants. Status unknown.

Timeline

10 January 2022

Primary endpoint
30 October 2022

31 March 2023

Quick facts

Lead sponsor	University Tunis El Manar
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	45
Start date	10 January 2022
Primary completion	30 October 2022
Estimated completion	31 March 2023
Sites	1 location across Tunisia

Drugs / interventions tested

pelvic radiograph

Conditions studied

Juvenile Idiopathic Arthritis Hip — all drugs for Juvenile Idiopathic Arthritis Hip →

Sponsor

University Tunis El Manar

Who can join

Adults 4 to 20, any sex, with Juvenile Idiopathic Arthritis Hip. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease in children affecting mobility and physical function. The hip involvement represents a frequent complication in JIA patients. The assessment of hip damage becomes a mandatory step in disease monitoring. However, radiological scoring was not standardized. This study aimed to compare the two scoring systems previously proposed, examine their repeatability and their intra and inter agreement.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Can pediatric rheumatologists apply available hip scoring systems in daily practice for juvenile idiopathic arthritis?
Maatallah K, Lassoued Ferjani H, Ben Nessib D, Dghaies A, et al · · 2025 · PMID 40224384 · DOI 10.3389/fped.2025.1436200

Verify or expand the search:

Other University Tunis El Manar trials

Trials by the same sponsor.

NCT07467967 — Impact of Date Consumption on Metabolic Control and Oxidative Stress in Patients With Type 2 Diabetes · NA · not yet recruiting
NCT07378904 — Sterile Water Injection vs Morphine for Renal Colic · NA · active not recruiting
NCT07313553 — Prevention of Rebound Pain After Axillary Block · NA · not yet recruiting
NCT07240961 — Lumbal Erector Spinae Plane Block for Pain Management After Total Hip Arthroplasty · NA · recruiting
NCT07194967 — Virtual Reality for Pain and Anxiety Relief in Labor · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05206968 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Tunis El Manar
Last refreshed: 25 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05206968.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing